SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

ChainLink is seeing increased market attention as community members debate its long-term potential as essential infrastructure for real-world assets and AI integration. While some investors are actively accumulating, others are expressing frustration over stagnant price action and are waiting for legislative developments to serve as a catalyst for growth.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

The SGOV ETF is trending as investors park capital in short-term U.S. Treasuries to navigate market volatility and secure yield while awaiting clearer economic signals. Community discussion centers on using the fund as a defensive 'parking spot' to preserve principal and generate steady monthly income amidst ongoing concerns regarding inflation, debt levels, and recession risks.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The Melania Trump meme coin is trending as a flashpoint for community debate, with participants actively discussing allegations that the token and related assets are part of a broader pump-and-dump scheme orchestrated by political figures. Investors are currently expressing intense frustration over significant portfolio losses, while skepticism regarding the token's legitimacy and long-term viability continues to dominate the discourse.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

CHPY is drawing significant attention from income-focused investors who favor its unique strategy of holding physical semiconductor stocks, which distinguishes it from many other YieldMax ETFs that rely solely on synthetic derivatives. While the semiconductor sector has experienced recent volatility, community members are actively debating the merits of long-term holding versus tactical rotation to manage NAV fluctuation, with many viewing the weekly distributions as a sustainable way to build passive income during market cycles.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently driven by heightened investor enthusiasm following positive analyst coverage that highlights its potential to evolve into a large-cap biotech entity. The community is actively debating the clinical prospects of soquelitinib, with many focusing on its competitive advantage as an oral treatment against current injectable standards while closely monitoring short interest and upcoming trial data presentations.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is trending as investors react to its recent workforce restructuring and the firm's strategic focus on expanding its crypto and digital asset footprint. The community is actively discussing the bank's role in high-profile IPO pipeline developments and evaluating its resilience against broader private credit liquidity concerns.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending as traders analyze its price consolidation and long-term utility within the expanding AI agent and tokenization ecosystem. The community remains focused on potential institutional adoption and regulatory catalysts while debating whether current levels offer a strategic accumulation opportunity.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is trending as the community rallies behind a major governance proposal to activate a fee switch and initiate a large-scale token burn, fueling optimism around protocol revenue and deflationary pressure. Traders are closely monitoring these governance developments and strategic institutional interest, while debating the potential for long-term supply reduction.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is drawing investor interest due to strong core performance in diagnostics and medical devices, alongside institutional buying activity following a recent earnings beat and upward guidance revision. While some market participants are focused on technical consolidation and healthcare sector rotation, others are closely watching the stock for potential accumulation opportunities amidst positive analyst sentiment.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The Bitwise XRP ETF is trending as investors debate XRP's long-term utility versus its sensitivity to broader crypto liquidity and regulatory developments. While some community members remain bullish on institutional adoption and cross-border payment potential, others are actively tracking recent price volatility, network activity divergences, and the ongoing legislative progress of the Clarity Act.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Adobe Systems (ADBE) Dipped More Than Broader Market Today

Adobe Systems (ADBE) closed the most recent trading day at $263.99, moving 2.4% from the previous trading session.

Adobe's President of Customer Experience Orchestration Business on building the American Dream

Adobe's President of Customer Experience Orchestration Business on building the American Dream...

HubSpot Q2 Earnings Beat: Can AI Growth Offset Slower Buying Cycles?

HubSpot topped estimates with 20% revenue growth and rising AI adoption, but longer sales cycles could challenge near-term expansion.

HubSpot Stock: Buy, Hold or Wait as Growth Meets Valuation Pressure

HubSpot pairs 20% revenue growth with stronger cash flow and AI adoption, but slower buying decisions and valuation pressure cloud the outlook.

Adobe vs. AppLovin: Which Technology Stock Is a Better Buy in 2026?

Key PointsAdobe maintains a dominant position in creative software with a net margin of 30% and growing enterprise capabilities...

Adobe vs. BigBear.ai: Which Technology Stock Is a Better Buy in 2026?

Key PointsAdobe maintains a dominant market position in creative software with high net margins and nearly $10 billion in free cash flow...

Adobe Stock Analysis: Buy or Sell?

Adobe (NASDAQ: ADBE) has disappointed investors in 2026...

Salesforce Declines 17% Over the Past Year: How to Play CRM Stock?

Salesforce's 17% drop reflects broader software pressure, but resilient growth, rising AI ARR and a lower valuation offer reasons to hold CRM.

Adobe vs. Arista Networks: Which Technology Stock Is a Better Buy in 2026?

Key PointsAdobe maintains a dominant position in creative software with integrated generative AI tools and a strong net margin of 30...

Why Adobe Systems (ADBE) Outpaced the Stock Market Today

Adobe Systems (ADBE) reached $265.15 at the closing of the latest trading day, reflecting a +1.89% change compared to its last close.

$ADBE Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $4.26 up 7.85% YoY
• Reported revenue of $6.62B up 12.69% YoY
• Adobe raised its full-year fiscal 2026 total revenue target to $26.50 billion to $26.60 billion and non-GAAP diluted EPS to $24.35 to $24.45, reflecting strong performance.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

CRM, NOW, INTU, ADBE: Software Stocks Slide After Figma Flags Surging AI Costs

Equity

Bearish Sentiment

Yes, buying

No, staying away

Just holding what I have

Watching from the sidelines

Lemonade ($LMND) stock is down over 20% after the company reported Q2 2026 earnings and announced a CFO succession plan, with longtime finance chief Tim Bixby set to transition to the board in January 2027. Are you buying the dip? Vote and explain your reasoning in the comments.

Lemonade ($LMND) is down sharply following Q2 earnings, with the market reacting to a CFO succession announcement alongside the results. Are you buying the dip?

Stocktwits

Lemonade Inc

) is down sharply following Q2 earnings, with the market reacting to a CFO succession announcement alongside the results. Are you buying the dip?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$6.07	--	--	N/A
Q2 '26	$5.82	$5.96	2.48%	BEAT
Q1 '26	$5.87	$6.06	3.20%	BEAT
Q4 '25	$5.40	$5.50	1.88%	BEAT
Q3 '25	$5.18	$5.31	2.41%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '26

Historical Earnings